Newsroom | Magellan Rx Management

March 14, 2022

Magellan Rx Management Achieves Perfect CMS Audit for Medicare Part D

Magellan Health, Inc. today announced that Magellan Rx Management (MRx), the full-service pharmacy benefit management division of the company, received a perfect audit score from the Centers for Medicare & Medicaid Services (CMS) for its Granite Alliance Insurance Company Employer Group Waiver Plan (EGWP), a type of Medicare Prescription Drug (Part D) plan.

March 3, 2022

Magellan Rx Management Releases Clinical Insights on the Use of Psychedelics in Treating Mental Health Conditions

PHOENIX – March 3, 2022 –Magellan Rx Management, the full-service pharmacy benefits management division of Magellan Health, Inc. today released its Clinical Insights publication titled Therapeutic Psychedelics: an Emerging Frontier in Mental Health.

February 1, 2022

Magellan Rx Management Collaborates with Zipline to Deliver Prescription Medications by Autonomous Aircraft

Kannapolis, NC – February 1, 2022 – Magellan Rx Management, the full-service pharmacy benefits management division of Magellan Health, Inc., and Zipline, the global leader in instant logistics, today announced a partnership to deliver prescription medications, including specialty medications that treat chronic, complex conditions, directly to patients’ homes via autonomous aircraft.

October 7, 2021

Magellan Rx Pharmacy Earns NABP Digital Pharmacy Accreditation

Magellan Health, Inc. (NASDAQ: MGLN), today announced that Magellan Rx Pharmacy LLC, Magellan Rx Management's specialty pharmacy division, has been accredited by the National Association of Boards of Pharmacy® (NABP®) for digital pharmacy practice.

September 15, 2021

Magellan Rx Management’s AIDS Drug Assistance Program Center of Excellence Expands Program That Significantly Improves Medication Adherence and Quality of Care for Patients with HIV

Magellan Rx Management, the full-service pharmacy benefits management division of Magellan Health, Inc. (NASDAQ: MGLN) has expanded Navigate Whole Health to include the AIDS Drug Assistance Program (ADAP) that applies an innovative and comprehensive approach to managing the quality of care for persons receiving treatment for HIV.

July 21, 2021

Magellan Rx Management Collaborates with mPulse Mobile to Address Social Isolation and Loneliness During COVID-19

Magellan Rx Management, a division of Magellan Health, Inc. (NASDAQ: MGLN), today released results from its collaboration with mPulse Mobile that addresses social isolation and loneliness.

July 8, 2021

Magellan Rx Management and Heuro Health Collaborate to Offer Live Behavioral Health Support and Wellness Coaching

Magellan Rx Management, a division of Magellan Health, Inc. (NASDAQ: MGLN), and Heuro, LLC, today announced that they are collaborating to provide live behavioral health support and wellness coaching through the Heuro Health app, offering members and providers a more effective, efficient, and engaging communication platform.

June 9, 2021

Magellan Rx Management Oncology Biosimilar Solution Delivers $40M+ in Annualized Savings for Early Adopter Health Plans

Magellan Rx Management, a division of Magellan Health, Inc. (NASDAQ: MGLN), today announced annualized savings of over $40 million for five health plan customers who were early adopters of its oncology biosimilar medical benefit drug management solution.

May 20, 2021

Magellan Rx Management’s Medical Pharmacy Trend Report Unlocks the Latest Trends and Emerging Strategies to Manage Rising Medical Benefit Specialty Drug Spend

Magellan Rx Management, a division of Magellan Health, Inc. (NASDAQ: MGLN), released its eleventh annual Medical Pharmacy Trend ReportTM, featuring a comprehensive view of provider-administered medical benefit drug trends—one of the largest drivers of total specialty drug spend.

April 8, 2021

Magellan Rx Management and Trapelo Health to Offer Precision Oncology Platform for Next-Generation Care

Magellan Rx Management, a division of Magellan Health, Inc. (NASDAQ: MGLN), and Trapelo Health, today announced that they are collaborating to champion a more comprehensive, integrated approach to value-based care in the new era of precision oncology treatments.

February 16, 2021

Magellan Rx Management and Health Partners Plans Achieve 5 Stars for the Medicare Star Ratings Measure: Statin Use in Persons with Diabetes

Magellan Health, Inc. (NASDAQ: MGLN) today announced that Magellan Rx Management (MRx), the pharmacy benefit management division of the company, has achieved 5 Stars from the Centers for Medicare & Medicaid Services (CMS) for its Statin Use in Persons with Diabetes (SUPD) measure as a result of a clinical program launched for Health Partners Plans (HPP), a not-for-profit managed healthcare organization offering a broad range of health coverage options through Health Partners Medicare, Health Partners (Medicaid) and KidzPartners (Children’s Health Insurance Program).

February 10, 2021

Magellan Rx Management Announces Pilot with Digital Health Company, Wellth

Magellan Rx Management, the full-service pharmacy benefits management division of Magellan Health, Inc. (NASDAQ: MGLN), announced today the implementation of a pilot to expand its digital health suite by offering Wellth, a digital behavioral change program, with the goal of improving medication adherence and overall health.

February 1, 2021

Magellan Rx Medical Pharmacy Solution Impact: 90% of New Authorizations for Oncology Biosimilars

Magellan Rx Management, a division of Magellan Health, Inc. (NASDAQ: MGLN), today released preliminary results from its oncology biosimilar medical pharmacy solution that targets new-to-market oncology therapeutic biosimilars.

January 28, 2021

Magellan Medicaid Administration Achieves ISO 9001 Certification

Magellan Health, Inc. (NASDAQ: MGLN) today announced that Magellan Medicaid Administration, Inc. (MMA), Magellan Rx Management’s Government Pharmacy Benefit Management (PBM) division, has earned ISO 9001:2015 certification for the design and delivery of pharmacy benefit administration for government contracts.

November 13, 2020

Magellan Rx Management Releases Fifth Annual Medicaid Pharmacy Trend Report

Magellan Rx Management, the full-service pharmacy benefits management division of Magellan Health, Inc. (NASDAQ: MGLN), released its fifth annual Medicaid Pharmacy Trend ReportTM, the industry’s leading report exclusively detailing trends in the Medicaid pharmacy fee-for-service (FFS) space and the only detailed source examining Medicaid FFS gross and net drug spend trends.

October 30, 2020

Magellan Rx Achieves URAC Reaccreditation

Magellan Health, Inc. (NASDAQ: MGLN) today announced that Magellan Rx , the pharmacy benefits management division of the company, has earned two re-accreditations from URAC demonstrating the highest level of commitment to quality healthcare.

September 22, 2020

Magellan Rx Management Earns NCQA Case Management Accreditation

Magellan Rx Management (MRx), the full-service Pharmacy Benefits Management (PBM) division of Magellan Health, Inc. (NASDAQ: MGLN), announced today, it has received National Committee for Quality Assurance (NCQA) Case Management (CM) Accreditation for the Complex Case Management program.

April 8, 2020

Magellan Rx Management Medical Pharmacy Trend Report Delivers Industry Insights and Forecasting in Notable 10th Edition

Magellan Rx Management, a division of Magellan Health, Inc. (NASDAQ: MGLN), released its tenth annual Medical Pharmacy Trend Report™, featuring a comprehensive view of medical benefit drug trends—one of the largest drivers of total specialty drug spend. For 10 years, Magellan Rx has produced the industry’s only detailed trend report that analyzes medical benefit drug claims for trends, data benchmarking, forecasting for significant categories, as well as current medical benefit drug management approaches.

December 10, 2019

Magellan Rx Medical Pharmacy Solutions Achieve $2 Billion Lifetime Savings for Health Plan Customers While Ensuring Quality Care to Members

PHOENIX--(BUSINESS WIRE)--Dec. 10, 2019-- Magellan Rx Management, a division of Magellan Health, Inc. (NASDAQ: MGLN), today announced that its medical pharmacy management programs achieved over $2.1 billion in combined, lifetime savings for current health plan customers enrolled in disease-specific programs. These programs are designed to mitigate rising medical pharmacy spend while maintaining a high quality of care for members.

November 25, 2019

Magellan Rx Management’s MRx Navigate Offers Integrated Care Management, Focused on Customer and Member Healthcare Needs

Phoenix, Ariz. – November 25, 2019 – Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (NASDAQ: MGLN), has launched MRx Navigate, a comprehensive care management program that offers integrated, high-touch and high-tech solutions, focusing on the patient wellness journey and simplifying the member healthcare experience. The program incorporates both pharmacy and medical data to provide a comprehensive and holistic view of the member.

November 14, 2019

Magellan Rx Management Live Vibrantly Diabetes Program Delivers Proven Results

PHOENIX--(BUSINESS WIRE)--Nov. 14, 2019-- Magellan Rx Management, a division of Magellan Health, Inc. (NASDAQ: MGLN), offers the Live Vibrantly Diabetes Management program, which improves diabetes outcomes with a holistic approach, leveraging expertise from a specialized multi-disciplinary team and dedicated wellness coaches to manage all aspects of diabetes. The overall goal of the program is to maximize health outcomes and reduce unnecessary costs by improving wellness, diet, and exercise along with optimizing medication use and adherence for patients with diabetes.

November 8, 2019

Magellan Rx Management, LLC Earns Accreditation from the National Committee for Quality Assurance

PHOENIX--(BUSINESS WIRE)--Nov. 8, 2019-- Magellan Rx Management, LLC, a division of Magellan Health, Inc. (NASDAQ: MGLN), today announced it was accredited by the National Committee for Quality Assurance (NCQA) for Utilization Management. NCQA Utilization Management Accreditation focuses on consumer protection and improvement in service to customers. Standards recognize that organizations that apply for accreditation have open access networks, and can improve service quality and utilize customized structures to meet purchaser needs.

September 25, 2019

Magellan Rx Management’s Live Vibrantly: Whole Health Program Leverages Behavioral Health and Opioid Management

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Sep. 25, 2019-- Magellan Rx Management, a division of Magellan Health, Inc. (NASDAQ: MGLN), offers an innovative, integrated approach to improving healthcare and cost of care outcomes with Live Vibrantly: Whole Health.

September 17, 2019

Magellan Rx Management’s Fourth Annual Medicaid Pharmacy Trend Report Details Trends in Medicaid Fee-for-Service Pharmacy Programs

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Sep. 17, 2019-- Magellan Rx Management, the full-service pharmacy benefits management division of Magellan Health, Inc. (NASDAQ: MGLN), today released its fourth annual Medicaid Pharmacy Trend ReportTM, the industry’s leading report that is developed through in-depth data analysis and supported by Magellan’s broad national experience managing fee-for-service (FFS) Medicaid pharmacy programs.

September 5, 2019

Magellan Rx Specialty Pharmacy Helps More Patients Achieve Adherence Goals through MRx Cares Clinical Coaching Program

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Sep. 5, 2019-- Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (NASDAQ: MGLN), today announced superior outcomes for members receiving specialty medications through MRx Specialty Pharmacy. Compared to benchmarks, members who utilize MRx Specialty Pharmacy were significantly more likely to reach and maintain adherence goals of 85 percent or greater – measured by proportion of days covered (PDC) - across all disease states.

June 18, 2019

Magellan Rx Management Pioneers Novel Drug Wastage Program, Savings Exceed $46 Million in First Year, While Promoting High Quality Care for Members

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Jun. 18, 2019-- Magellan Rx Management, the pharmacy benefit management (PBM) division ofMagellan Health, Inc. (NASDAQ: MGLN), has launched an innovative solution to control spend for high-cost infusible drugs, while promoting high quality care for members.

June 4, 2019

Magellan Rx Management Launches Oncology Biosimilar Medical Pharmacy Solution, Aims to Improve Member Access, Reduce Costs and Save Customers Millions in Drug Spend

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Jun. 4, 2019-- Magellan Rx Management, the pharmacy benefit management (PBM) division ofMagellan Health, Inc. (NASDAQ: MGLN), today announced the launch of a medical pharmacy solution targeting oncology therapeutic biosimilars. In preparation for the expected 2019 market entry of oncology biosimilars, the solution aims to educate customers, members and providers through the implementation of individualized strategies that consider clinical, financial and regulatory factors. This will ultimately result in maintaining or expanding member access to clinically-effective treatments, while having the added benefit of delivering significant drug spend savings for participating customers.

May 20, 2019

Magellan Rx Management’s Second Annual Employer Market Insights Report Highlights Market Dynamics and Opportunities for Traditional and Specialty Drugs

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--May 20, 2019-- Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (NASDAQ:MGLN) today released its second Employer Market Insights Report, which highlights key areas of pharmacy trend and spend. The report also provides exclusive drug forecasts and management strategies to help employers address and solve for challenges and capture opportunities that exist in the marketplace across both the pharmacy and medical benefits, while promoting improved health outcomes for members.

April 16, 2019

Magellan Rx Management Biosimilar Program Shifts Infliximab Utilization by 86% in First Year, Resulting in 34% Drug Cost Savings

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Apr. 16, 2019-- Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (NASDAQ: MGLN), released new data today showcasing results from its medical pharmacy program focused on biosimilar management. The results revealed that health plan organizations saw a significant shift in utilization from high-cost drugs to lower-cost biosimilar formulations after implementation of a medical benefit drug management solution, yielding substantial drug cost savings while maintaining a high level of clinical quality.

February 19, 2019

Magellan Rx Management Medical Pharmacy Trend Report Shows Record Increase in Commercial PMPM Trends

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Feb. 19, 2019-- Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (NASDAQ: MGLN) released its ninth annual Medical Pharmacy Trend Report. The benchmark report is the industry’s premier detailed resource that offers data for analyzing medical benefit drug claims as well as current medical benefit drug management strategies.

October 24, 2018

Magellan Rx Management’s Third Annual Medicaid Pharmacy Trend Report Highlights Opportunities for Medicaid Fee-for-Service Pharmacy Programs

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Oct. 24, 2018-- Magellan Rx Management, the full-service pharmacy benefits management division of Magellan Health, Inc. (NASDAQ:MGLN), today released its third annual Medicaid Pharmacy Trend Report. Developed through in-depth data analysis and supported by Magellan’s broad national experience managing fee-for-service (FFS) Medicaidpharmacy programs, this third edition report examines clinically-appropriate drug use, cost-saving opportunities and provides a detailed look into the increase of specialty trend, Medicaid drugs in the pipeline, and the effect of the opioid epidemic.

October 17, 2018

Magellan Rx Management Launches New Predictive Analytic Capabilities with MRx Predict

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Oct. 17, 2018-- Magellan Rx Management, the full-service pharmacy benefits management division of Magellan Health, Inc. (NASDAQ:MGLN), announced the launch of MRx Predict, a new advanced analytics capability that proactively identifies patients at-risk of experiencing adverse events, and forecasts future drug cost drivers for customers.

May 1, 2018

Magellan Health to Participate at HLTH: The Future of Healthcare Conference

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--May 1, 2018-- Magellan Health, Inc. (NASDAQ: MGLN) today announced that Sam Srivastava, chief executive officer of Magellan Healthcare, and Mostafa Kamal, chief executive officer of Magellan Rx Management, will participate in panel discussions at HLTH: The Future of Healthcare Conference at the ARIA Resort and Casino in Las Vegas, NV.

April 19, 2018

Magellan Rx Management Releases New Employer Market Insights Report

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Apr. 19, 2018-- Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (NASDAQ:MGLN) today released its first Employer Market Insights Report, which highlights key areas of pharmacy trend and spend, and provides exclusive forecasting information to help employers better plan for the future.

April 17, 2018

Magellan Rx Management announces results from Hemophilia Management Program in honor of World Hemophilia Day

Scottsdale, Ariz. – Magellan Health, Inc. (NASDAQ: MGLN) today announced that Magellan Rx Management, the pharmacy benefit management division of the company, has released results from the first six months of its hemophilia management program launched in collaboration with Health New England, a non-profit health plan serving the commercial, Medicaid and Medicare markets.

March 1, 2018

Magellan Rx Management’s Annual Medical Pharmacy Trend Report Released

Scottsdale, Ariz. – Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (NASDAQ: MGLN) today released its eighth annual Medical Pharmacy Trend Report, which is the industry’s leading resource for benchmarking key trends, analytics and approaches to managing high-cost specialty drugs paid under the medical benefit.

January 16, 2018

Magellan Health Continues Innovation and Efforts to Improve Outcomes for Patients with Substance Use Disorder

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) has long been the national leader in the use of digital innovation to help those struggling with various medical and behavioral conditions, including Substance Use Disorders (SUD). As a pioneer in the use of digital therapeutics and computerized cognitive behavioral therapy (CCBT), Magellan has engaged in a new initiative designed to measure clinical outcomes in patients with SUD by leveraging reSET®, the first ever FDA cleared prescription digital therapeutic from PEAR Therapeutics.

November 9, 2017

Magellan Rx Management CEO Mostafa Kamal Named to Shatterproof's Substance Use Disorder Treatment Task Force

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) today announced that Mostafa Kamal, chief executive officer of Magellan Rx Management, has been named to the Substance Use Disorder Treatment Task Force, founded by Shatterproof. The mission of the task force is to "fundamentally improve substance use disorder (SUD) treatment in the United States, in terms of both quality and patient outcomes."

September 13, 2017

Magellan Rx Management's Second Annual Medicaid Trend Report Highlights Opportunities for More Innovative State Specialty Drug Management

SCOTTSDALE, Ariz.--Magellan Rx Management, the pharmacy benefits management division of Magellan Health, Inc. (NASDAQ: MGLN), today released its second annual Medicaid Trend Report. Developed through in-depth data analysis and supported by Magellan's broad national experience managing the fee-for-service (FFS) Medicaid pharmacy programs the report provides detailed insights into the pharmacy economics that drive trend and the cost of care, uncovering real opportunities for states to get more engaged and innovative when it comes to pharmacy management, particularly in specialty.

August 1, 2017

Magellan Rx Management Collaborates with Health New England to Launch New Hemophilia Management Program

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) today announced that Magellan Rx Management, the pharmacy benefit management division of the company, has launched a hemophilia management program in collaboration with Health New England, a non-profit health plan serving the commercial, Medicaid and Medicare markets.

May 9, 2017

Magellan Health to Present at Barclays Pharmacy Benefit Management & Drug Pricing Symposium

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) announced today that Mostafa Kamal, chief executive officer of Magellan Rx Management, the company's pharmacy benefit management division, will participate in a panel at the Barclays Pharmacy Benefit Management and Drug Pricing Symposium in New York on Thursday, May 25, 2017.

April 21, 2017

Magellan Rx Management Earns URAC Reaccreditation in Pharmacy Benefit Management

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) today announced that Magellan Rx Management, the company's pharmacy benefit management (PBM) division, through its subsidiary Magellan Pharmacy Solutions, has earned URAC reaccreditation in Pharmacy Benefit Management for the commercial and managed care lines of business.

April 3, 2017

Magellan Rx Management's Medical Pharmacy Trend Report Highlights Member and Payer Impact of High-Cost Specialty Drugs Billed on the Medical Benefit

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (NASDAQ: MGLN) today released its seventh annual Medical Pharmacy Trend Report, which continues to be a leading source for payers and other industry stakeholders to analyze high-cost injectable drugs paid under the medical benefit.

February 20, 2017

Magellan Health Selected as One of Fortune Magazine's World's Most Admired Companies

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ:MGLN) today announced that it has been selected as one of Fortune Magazine's World's Most Admired Companies. The list is a ranking of the world's most respected and reputable companies, as ranked by peers in its respective industry.

November 21, 2016

Magellan Health to Acquire Veridicus Holdings, LLC

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ:MGLN) today announced that it has entered into an agreement to acquire Veridicus Holdings, LLC, a privately held pharmacy benefit management (PBM) organization with a unique set of clinical services and capabilities. Veridicus' differentiated approach to pharmacy management leverages proprietary analytics and clinical software that integrates pharmacy, medical and lab data to drive targeted interventions resulting in better health outcomes and lower costs for complex patient populations.

September 22, 2016

Magellan Rx Management's Medicaid Trend Report Highlights Strategies for States to Improve Care, Lower Costs

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (NASDAQ: MGLN) today released its Medicaid Trend Report, developed through in-depth data analysis and supported by Magellan's broad national experience managing the fee-for-service (FFS) Medicaid pharmacy programs for 25 states and Washington, D.C. The report, the first of its kind, examines clinically appropriate drug use and cost-savings opportunities for Medicaid FFS programs across the country.

September 7, 2016

Magellan Rx Management's 2016 Specialty Summit Sets Attendance Record; Brings Together Industry Experts to Discuss Complex Pharmacy Challenges

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health (NASDAQ: MGLN) recently hosted its 13th annual Specialty Summit, an open forum where industry experts share progressive solutions for today's complex pharmacy challenges. The 2016 summit set attendance records with well over 500 attendees - a more than 42 percent increase over last year's conference - bringing together a targeted cross-section of those within the industry focused on the challenging and most costly area of spend.

August 16, 2016

Magellan Health Collaborates with Bayer to Educate Members and Clinicians about Availability of Long-Acting Reversible Contraceptives

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) announced today that it has collaborated with Bayer to launch an education initiative designed to focus on women's health and reduce the rate of unintended pregnancies through the appropriate utilization of long-acting reversible contraceptives (LARC). Magellan Healthcare has launched an outreach campaign to improve education about and access to the full range of contraceptive methods for Magellan Complete Care of Florida members.

June 12, 2016

Magellan Health Opens Toll-Free Number to Assist Individuals after Mass Shooting at Orlando Night Club

Individuals can call toll-free number to talk to trained professionals SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) today announced that in response to a mass shooting at a night club in Orlando it has set up a 24-hour toll-free hotline for individuals to access, regardless of whether or not they are Magellan members.

June 7, 2016

Magellan Health to Present at Barclays Select Series Pharmacy Benefit Management & Drug Pricing Symposium

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) announced today that Todd Lord, vice president of clinical strategy at Magellan Rx Management, the company's pharmacy benefit management division, will participate in two panel discussions at the Barclays Select Series Pharmacy Benefit Management and Drug Pricing Symposium in New York on Wednesday, June 15, 2016 from 11:15 a.m.-12:15 p.m. Eastern.

April 29, 2016

Magellan Rx Management's Site of Service Program Saves Two Regional Health Plans a Total of More Than $1 Million Over Six Months

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (NASDAQ: MGLN), today announced that its clinical site of service program has delivered a total of more than $1 million dollars in savings in the first six months for two regional health plans, while generating positive feedback from patients.

April 8, 2016

Magellan Rx Management Selected as a Preferred Provider for Mercer Rx Options

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (NASDAQ: MGLN), announced today that it has been selected as a preferred provider in Mercer's Rx Options, a pharmacy collective program for plan sponsors with 50 to 1,500 employees.

February 17, 2016

Magellan Health Releases Sixth Annual Medical Pharmacy Trend Report

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (NASDAQ: MGLN), today released its sixth annual Medical Pharmacy Trend Report, which includes data from 59 commercial payers representing approximately 130 million covered lives.

October 26, 2015

Updated Time: Magellan Health to Present at 24th Annual Credit Suisse Healthcare Conference

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) today announced that Jonathan Rubin, chief financial officer of Magellan Health, and Mostafa Kamal, chief executive officer of Magellan Rx Management, the company's pharmacy management division, will present at the 24th annual Credit Suisse Healthcare Conference.

October 15, 2015

Magellan Health to Present at 24th Annual Credit Suisse Healthcare Conference

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) today announced that Jonathan Rubin, chief financial officer of Magellan Health, and Mostafa Kamal, chief executive officer of Magellan Rx Management, the company's pharmacy management division, will present at the 24th annual Credit Suisse Healthcare Conference.

October 2, 2015

Magellan Health to Present at Barclays Select Series Biosimilars Symposium

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) announced today that Mostafa Kamal, chief executive officer of Magellan Rx Management, the company's pharmacy benefit management division, will participate in a panel discussion at the Barclays Select Series Biosimilars Symposium.

September 11, 2015

Magellan Rx Management Hosts 12th Annual Specialty Summit

Sold-out crowd discusses PCSK9 impact, Hep-C treatment, among other topics of interest across the industry SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- A sold-out crowd gathered in New York City from September 1-3, 2015, where Magellan Rx Management, the pharmacy benefit management division of Magellan Health, Inc. (NASDAQ: MGLN) recently hosted its 12th annual Specialty Summit.

August 28, 2015

Magellan Rx Management Offers Key Strategies to Manage PCSK9 Therapies

Payers need innovative solutions for new class of costly drugs SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Following the approval of evolocumab (Repatha™; Amgen) by the Food and Drug Administration (FDA) yesterday, Magellan Rx Management, the pharmacy benefit management division of Magellan Health, Inc. (NASDAQ: MGLN), today announced its ability to assist employers, health plans and Medicaid programs in appropriately managing the use of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitor medications.

June 4, 2015

Magellan Health Announces New Business Unit Alignment and Business CEO Transitions

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ:MGLN) today announced that in order to further focus and advance its two growth initiatives - Magellan Complete Care and Magellan Rx Management - the company will be organized into two primary business units going forward - Magellan Healthcare and Magellan Rx Management.

March 18, 2015

Magellan to Acquire 4D Pharmacy Management Systems, Inc.

Full-Service PBM Will Increase Magellan Rx Management's Scale, Provide Medicare Part D Expertise SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ:MGLN) today announced that it has entered into an agreement to acquire 4D Pharmacy Management Systems, (4D), a privately held, full-service pharmacy benefit manager (PBM) headquartered in Troy, Mich., serving managed care organizations (MCOs), employers and government-sponsored benefit programs, such as Medicare Part D plans.

March 16, 2015

Magellan Rx Management's Fifth Annual Medical Pharmacy Trend Report Details Trends and Challenges Facing Payors

The only comprehensive source for current medical benefit drug management approaches and data benchmarking SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Rx Management, a division of Magellan Health, Inc. (NASDAQ: MGLN), today released its fifth annual Medical Pharmacy Trend Report, the only industry benchmark of its kind to analyze high cost injectable drugs paid under the medical benefit.

September 29, 2014

Magellan Health's Pharmacy Business Obtains URAC Accreditation

Accreditation demonstrates commitment to quality healthcare SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) today announced its pharmacy business, Magellan Rx Management, has obtained accreditations in Health Utilization Management, version 7.0, and Specialty Pharmacy, version 2.0, from URAC.

August 21, 2014

Magellan Rx Management to Host 11th Annual Specialty Summit in New York City

AVON, Conn.--(BUSINESS WIRE)-- Magellan Rx Management, part of Magellan Health, Inc. (NASDAQ: MGLN), will host its 11th annual Specialty Summit, from September 10 through September 12 in New York City. The summit will bring together national thought leaders for insightful discussions regarding the specialty drug landscape and will cover key issues and emerging trends in major therapeutic categories.

May 7, 2014

Magellan Rx Management's Fourth Annual Medical Pharmacy Trend Report Reveals Opportunities for Payors to Better Manage Care, Reduce Costs

Magellan's report is the only benchmark of its kind for drugs paid under the Medical Benefit AVON, Conn.--(BUSINESS WIRE)-- Magellan Rx Management, a division of Magellan Health Services, Inc. (NASDAQ: MGLN), today released its fourth annual Medical Pharmacy Trend Report, the only industry benchmark of its kind to analyze high cost injectable drugs paid under the medical benefit, including those drugs used to treat complex conditions such as cancer, rheumatoid arthritis and multiple sclerosis.

March 20, 2014

Magellan Rx Management Launches Audit Tool to Help Determine PBM Effectiveness

Offered Complimentary for a Limited Time AVON, Conn.--(BUSINESS WIRE)-- Magellan Rx Management, a division of Magellan Health Services, Inc. (NASDAQ: MGLN), today announced the launch of MRxAudit, a comprehensive tool to help determine the effectiveness of pharmacy benefit management services.

January 13, 2014

Magellan Health Services Announces Reorganized, Rebranded Pharmacy Organization, Magellan Rx Management

Integrated pharmacy organization balances quality care with effective cost management AVON, Conn.--(BUSINESS WIRE)-- Magellan Health Services (NASDAQ: MGLN) today announced its reorganized and rebranded pharmacy organization, Magellan Rx Management.